Identification of integrin a5b1 inhibition as a potentially disease-modifying approach for the treatment of pulmonary arterial hypertension

Mónica S. Montesinos(Universidad de La Laguna), Min Lü(Central South University), Qi Qiao(Jilin University), Hua Wang(Maine Farmland Trust), Adrian S. Ray(Maine Farmland Trust), Bryan Goodwin(Maine Farmland Trust), François Potus(Queen's University), James J. Dowling(Maine Farmland Trust), Inese Smukste, Steeve Provencher(Institut universitaire de cardiologie et de pneumologie de Québec), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Meghan Monroy(Brandeis University), Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Minh‐Hai Nguyen(Brandeis University), Olivier Boucherat(Lung Institute), Sandra Breuils‐Bonnet, Parmita Saxena(Brandeis University), Mélanie Sauvaget(Canadian Heart Research Centre), Jessica R. Pondish(Brandeis University), Charlie Théberge(Canadian Heart Research Centre), Hae Jin Kim(Brandeis University), Fu‐Yang Lin(Maine Farmland Trust), Elizabeth H. Konopka(Brandeis University), Muzaffar Akram(Maine Farmland Trust), Andrew Mcteague(Brandeis University), Blaise Lippa(Maine Farmland Trust), Hailey Rapisardi(Brandeis University), Terence I. Moy(Maine Farmland Trust)
Unknown
September 14, 2024
Cited by 0


Related Papers